The trajectory of Sildenafil presents a intricate picture for investors. While the initial launch generated significant gains, the expiration of its patent opened the door to generic versions, dramatically diminishing https://privatebookmark.com/story21630926/the-copyright-and-the-pharmaceutical-industry-a-risky-opportunity